Parallax Volatility Advisers’s VanEck Pharmaceutical ETF PPH Stock Holding History

Parallax Volatility Advisers’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-5,741	Closed	-$357K	–	3112
2020 Q3	$357K	Buy	+5,741	New	+$363K	﹤0.01%	2351
2019 Q3	–	Sell	-1	Closed	–	–	3166
2019 Q2	$0	Hold	1	–	–	﹤0.01%	3434
2019 Q1	$0	Hold	1	–	–	﹤0.01%	3709
2018 Q4	$0	Hold	1	–	–	﹤0.01%	3672
2018 Q3	$0	Hold	1	–	–	﹤0.01%	3328
2018 Q2	$0	Hold	1	–	–	﹤0.01%	3002
2018 Q1	$0	Hold	1	–	–	﹤0.01%	3741
2017 Q4	$0	Hold	1	–	–	﹤0.01%	4667
2017 Q3	$0	Hold	1	–	–	﹤0.01%	2962
2017 Q2	$0	Hold	1	–	–	﹤0.01%	3524
2017 Q1	$0	Hold	1	–	–	﹤0.01%	4372
2016 Q4	$0	Hold	1	–	–	﹤0.01%	3860
2016 Q3	$0	Hold	1	–	–	﹤0.01%	3658
2016 Q2	$0	Hold	1	–	–	﹤0.01%	3269
2016 Q1	$0	Hold	1	–	–	﹤0.01%	3373
2015 Q4	$0	Hold	1	–	–	﹤0.01%	3613
2015 Q3	$0	Hold	1	–	–	﹤0.01%	3806
2015 Q2	$0	Hold	1	–	–	﹤0.01%	4592
2015 Q1	$0	Hold	1	–	–	﹤0.01%	5225
2014 Q4	$0	Buy	+1	New	+$64	﹤0.01%	5618

Other funds holding PPH

MTWSIF

Mivtachim The Workers Social Insurance Fund Tel Aviv, Israel $789M AUM 73.25% 1-Year Est. Return

CCP

Clough Capital Partners Boston, Massachusetts $1.04B AUM 49.7% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BCI

Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

22CM

20/20 Capital Management Costa Mesa, California $386M AUM 30.28% 1-Year Est. Return

OPS

Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Parallax Volatility Advisers's PPH Position: Q4 2020 in Review

Parallax Volatility Advisers sold out of VanEck Pharmaceutical ETF (PPH) in Q4 2020, closing a stake of 5,741 shares — an estimated $357K sold.

Parallax Volatility Advisers first reported a position in PPH in Q4 2014 and held it in 20 quarters. The position peaked at $357K in Q3 2020. 49 funds tracked by Wall St. Rank hold PPH as of Q4 2020.

Parallax Volatility Advisers reported no remaining VanEck Pharmaceutical ETF position as of Q4 2020 after selling out during the quarter.
Parallax Volatility Advisers sold 5,741 VanEck Pharmaceutical ETF shares in Q4 2020, an estimated $357K.
Parallax Volatility Advisers first reported a position in VanEck Pharmaceutical ETF in Q4 2014 and held it in 20 quarters.
Parallax Volatility Advisers's VanEck Pharmaceutical ETF position peaked at $357K in Q3 2020.
49 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q4 2020.

Based on Parallax Volatility Advisers's 13F filing for Q4 2020, filed 16 Feb 2021.